Every open market buy and sale of Ginkgo Bioworks Holdings, Inc. stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are only selling over the last 12 months: $0 bought and $5M sold.
Buying and selling by month
open market, last 12 monthsGet an alert when DNA insiders trade
We read every Form 4 the moment the SEC posts it and tell you when an DNA officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.
Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.
Every DNA insider trade
2 years · newest first| Insider | Type | Price | Held after | Filed | |||
|---|---|---|---|---|---|---|---|
| Oct 19, 2026 | Jason R KellySee remarks | Sale | 45,682 | $10.14 | $463K | 129,065 | Oct 21Form 4 |
| Oct 19, 2026 | Reshma P. ShettySee remarks | Sale | 41,172 | $10.14 | $418K | 356,329 | Oct 21Form 4 |
| Oct 19, 2026 | Barry Canton10% owner | Sale | 41,172 | $10.14 | $418K | 453,951 | Oct 21Form 4 |
| Oct 19, 2026 | Steven P. CoenSee remarks | Sale | 766 | $10.14 | $8K | 50,168 | Oct 21Form 4 |
| Oct 5, 2026 | Steven P. CoenSee remarks | Sale | 2,403 | $15.00 | $36K | 49,448 | Oct 7Form 4 |
| Sep 15, 2026 | Christian O HenryDirector | Sale | 5,000 | $7.08 | $35K | 19,310 | Sep 16Form 4 |
| Aug 24, 2026 | Steven P. CoenSee remarks | Sale | 330 | $6.98 | $2K | 51,851 | Aug 25Form 4 |
| Jul 17, 2026 | Steven P. CoenSee remarks | Sale | 752 | $7.90 | $6K | 51,438 | Jul 20Form 4 |
| May 22, 2026 | Steven P. CoenSee remarks | Sale | 307 | $8.33 | $3K | 50,704 | May 26Form 4 |
| Apr 17, 2026 | Steven P. CoenSee remarks | Sale | 324 | $7.95 | $3K | 50,268 | Apr 20Form 4 |
| Apr 13, 2026 | Steven P. CoenSee remarks | Sale | 33,171 | $6.41 | $213K | 49,849 | Apr 14Form 4 |
| Apr 10, 2026 | Reshma P. ShettySee remarks | Sale | 124,727 | $6.43 | $802K | 436,422 | Apr 13Form 4 |
| Apr 10, 2026 | Barry Canton10% owner | Sale | 124,727 | $6.43 | $802K | 436,422 | Apr 13Form 4 |
| Apr 9, 2026 | Jason R KellySee remarks | Sale | 206,782 | $6.65 | $1.4M | 316,483 | Apr 10Form 4 |
| Apr 9, 2026 | Barry Canton10% owner | Sale | 26,271 | $6.66 | $175K | 338,568 | Apr 10Form 4 |
DNA insider trading FAQ
Are DNA insiders buying or selling?
Insiders are only selling over the last 12 months. 0 insiders bought $0 of DNA on the open market in 0 trades, and 5 sold $5M in 19 trades.
When did an DNA insider last buy shares?
There has been no open market insider purchase of DNA in the last two years.
When did an DNA insider last sell shares?
Jason R Kelly (See remarks) sold 45,682 shares for $463K on Oct 19, 2026.
What is a Form 4?
Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.
Why do insider sales matter less than buys?
Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.
From SEC Form 4 filings · Not investment advice
